↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"

A　B　C　D　E　F　G　H　 I 　J　K　L　M　N　O　P　Q　R　S　T　U　V　W　X　Y　Z　other

71 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名（臨床試験情報から抽出）   DrugBank   KEGG DRUG *   KEGG GENES *   KEGG PATHWAY   指定難病告示番号 * 
 1   1-deoxynojirimycin   Duvoglustat   D09605   1件: GAA   4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism   1件:
256 
 2   1-deoxynojirimycin hydrochloride   Duvoglustat   D09605   1件: GAA   4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism   1件:
256 
 3   Aav2/8lsphgaa   -   -   -   -   1件:
256 
 4   Acetaminophen   Acetaminophen   D00217   2件: PTGS1, PTGS2   21件: Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway   11件:
13,
34,
35,
46,
49,
51,
70,
86,
231,
256,
271 
 5   Acid alpha glucosidase   Alglucosidase alfa   D03207   1件: GAA   4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism   1件:
256 
 6   Albuterol   Salbutamol   D02147   1件: ADRB2   8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   8件:
12,
13,
86,
89,
113,
231,
256,
299 
 7   Alglucosidase alfa   Alglucosidase alfa   D03207   1件: GAA   4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism   1件:
256 
 8   Alglucosidase alfa (gz419829)   Alglucosidase alfa   D03207   1件: GAA   4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism   1件:
256 
 9   Alglucosidase alfa (myozyme)   Alglucosidase alfa   D03207   1件: GAA   4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism   1件:
256 
 10   Alglucosidase alfa (recombinant human acid alpha-glucosidase [rhgaa])   Alglucosidase alfa   D03207   1件: GAA   4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism   1件:
256 
 11   Alglucosidase alfa gz419829   Alglucosidase alfa   D03207   1件: GAA   4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism   1件:
256 
 12   Alglucosidase alpha   -   -   -   -   1件:
256 
 13   Alpha glucosidase   Alglucosidase alfa   D03207   1件: GAA   4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism   1件:
256 
 14   Alpha-glucosidase   Alglucosidase alfa   D03207   1件: GAA   4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism   1件:
256 
 15   At2220   At2220   -   -   -   1件:
256 
 16   At2221   -   -   -   -   1件:
256 
 17   Atb200   -   -   -   -   1件:
256 
 18   Avalglucosidase alfa gz402666   -   -   -   -   1件:
256 
 19   Avalglucosidase alfa(gz402666)   -   -   -   -   1件:
256 
 20   Beta-hydroxybuturate esters   -   -   -   -   1件:
256 
 21   Bmn 701   -   -   -   -   1件:
256 
 22   Bortezomib   Bortezomib   D03150   1件: PSMB5   1件: Proteasome   13件:
11,
26,
28,
46,
49,
51,
61,
63,
66,
228,
256,
288,
331 
 23   Clenbuterol   Clenbuterol   D07713   1件: ADRB2   8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   2件:
1,
256 
 24   Deoxynojirimycin   Duvoglustat   D09605   1件: GAA   4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism   1件:
256 
 25   Deprakine   -   -   -   -   1件:
256 
 26   Diphenhydramine   Diphenhydramine   D00300, D00669, D02419, D03285, D03360, D03854   1件: HRH1   3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction   5件:
49,
51,
70,
86,
256 
 27   Duvoglustat   Duvoglustat   D09605   1件: GAA   4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism   1件:
256 
 28   Duvoglustat hcl   Duvoglustat   D09605   1件: GAA   4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism   1件:
256 
 29   Duvoglustat hydrochloride   Duvoglustat   D09605   1件: GAA   4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism   1件:
256 
 30   Enzyme replacement agent   -   -   -   -   1件:
256 
 31   Epilim chrono 200 controlled released tablets   -   -   -   -   1件:
256 
 32   Epilim chrono 300 controlled released tablets   -   -   -   -   1件:
256 
 33   Epilim chrono 500 controlled released tablets   -   -   -   -   1件:
256 
 34   Glucosidase alfa   -   -   -   -   1件:
256 
 35   Glycosade   -   -   -   -   3件:
65,
256,
257 
 36   Gz402666   -   -   -   -   1件:
256 
 37   Intravenous immune globulin   -   -   -   -   1件:
256 
 38   Lidocaine   Lidocaine   D00358, D02086, D08127   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   8件:
6,
13,
46,
86,
168,
226,
231,
256 
 39   Lmx 4 topical cream   -   -   -   -   1件:
256 
 40   Mannose   Mannose   -   -   -   2件:
13,
256 
 41   Methotrexate   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   4件: Antifolate resistance, Folate biosynthesis, Metabolic pathways, One carbon pool by folate   33件:
11,
13,
19,
34,
35,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
55,
56,
60,
62,
65,
84,
93,
96,
97,
162,
164,
172,
256,
271,
284,
285,
326,
331 
 42   Miglustat   Miglustat   D05032   1件: UGCG   2件: Metabolic pathways, Sphingolipid metabolism   3件:
19,
256,
299 
 43   Myozyme   Alglucosidase alfa   D03207   1件: GAA   4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism   1件:
256 
 44   Myozyme (alglucosidase alfa)   Alglucosidase alfa   D03207   1件: GAA   4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism   1件:
256 
 45   Myozyme 50 mg powder for concentrate for solution for infusion   Alglucosidase alfa   D03207   1件: GAA   4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism   1件:
256 
 46   Myozyme®   Alglucosidase alfa   D03207   1件: GAA   4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism   1件:
256 
 47   N.a.   -   -   -   -   8件:
3,
6,
8,
13,
46,
97,
240,
256 
 48   Neogaa   -   -   -   -   1件:
256 
 49   Phosphate   Phosphate ion   -   -   -   29件:
2,
3,
11,
12,
13,
28,
36,
46,
49,
51,
53,
60,
62,
65,
70,
78,
81,
83,
90,
96,
97,
164,
235,
256,
283,
284,
285,
286,
299 
 50   Pyridostigmine   Pyridostigmine   D00487   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   4件:
3,
6,
11,
256 
 51   Pyridostigmine bromide   Pyridostigmine   D00487   1件: ACHE   2件: Cholinergic synapse, Glycerophospholipid metabolism   3件:
3,
6,
256 
 52   Raav1-cmv-gaa (study agent) administration   -   -   -   -   1件:
256 
 53   Rapamycin   Sirolimus   D00753   1件: MTOR   43件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway   16件:
2,
15,
34,
35,
46,
49,
51,
60,
61,
67,
86,
89,
158,
256,
278,
279 
 54   Recombinant human ?-glucosidase conjugated with synthetic bismannose-6-phosphate-man6 glycan   Phosphate ion   -   -   -   1件:
256 
 55   Recombinant human a-glucosidase conjugated with multiple copies of synthetic bis-mannose-6-phosphate-tetra-mannose glycan (neogaa)   Mannose   -   -   -   1件:
256 
 56   Recombinant human acid alfa-glucosidase (rhgaa)   -   -   -   -   1件:
256 
 57   Recombinant human acid alpha-glucosidase (rhgaa)   Alglucosidase alfa   D03207   1件: GAA   4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism   1件:
256 
 58   Rhgaa   -   -   -   -   1件:
256 
 59   Rhgaa, acid alpha glucosidase   Alglucosidase alfa   D03207   1件: GAA   4件: Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism   1件:
256 
 60   Rituxan   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   4件:
46,
60,
256,
288 
 61   Rituximab   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   42件:
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331 
 62   Salbutamol   Salbutamol   D02147   1件: ADRB2   8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   8件:
3,
11,
49,
85,
86,
228,
256,
299 
 63   Sodium valproate   Valproic acid   D00399   7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2   17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism   4件:
2,
90,
102,
256 
 64   Ss-hydroxybuturate esters   -   -   -   -   1件:
256 
 65   Triheptanoin   Triheptanoin   D11465   -   -   10件:
2,
8,
120,
149,
156,
248,
256,
257,
317,
324 
 66   Ux007   -   -   -   -   4件:
8,
248,
256,
257 
 67   Val-1221   -   -   -   -   1件:
256 
 68   Valproate   Valproic acid   D00399   7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2   17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism   6件:
2,
3,
90,
102,
233,
256 
 69   Valproic acid   Valproic acid   D00399   7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2   17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism   10件:
3,
5,
26,
34,
65,
89,
90,
222,
256,
331 
 70   Zavesca   Miglustat   D05032   1件: UGCG   2件: Metabolic pathways, Sphingolipid metabolism   3件:
19,
256,
299 
 71   Zavesca® prescription   -   -   -   -   1件:
256 

先頭へ